期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖皮质激素联合重组人促血小板生成素治疗特发性血小板减少性紫癜 被引量：21

Corticosteroids Combined with Recombinant Human Thrombopoietin Treatment of Idiopathic Thrombocytopenic Purpura
暂未订购
导出
摘要 目的评价糖皮质激素联合重组人促血小板生成素(rhTPO)对特发性血小板减少性紫癜(ITP)患者的疗效和安全性。方法治疗组21例ITP患者常规应用糖皮质激素同时皮下注射rhTPO 15 000 u/d;对照组20例常规应用糖皮质激素治疗,动态监测血小板生长情况,并比较两组治疗效果。结果治疗组较对照组有效率明显提高(P<0.05);且治疗组血小板上升时间明显短于对照组(P<0.01);降低了ITP患者出血的危险性,且不良反应少。结论糖皮质激素联合rhTPO治疗ITP疗效确切,用药安全。
作者 杜以萍 张充力 毕珍宁
机构地区 青岛市第八人民医院 青岛市中心血站
出处 《血栓与止血学》 2014年第2期79-80,共2页 Chinese Journal of Thrombosis and Hemostasis
关键词 重组人促血小板生成素 特发性血小板减少性紫癜 疗效
分类号 R558 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献9

二级参考文献33

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量：104
  • 2吴秋玲,何静,陈燕,宋善俊.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的临床研究[J].华中科技大学学报（医学版）,2004,33(3):297-299. 被引量：13
  • 3Vadhan-Raj S,Murray L J,Bueso-Ramos C et al.Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patinents with cancer.Ann Intern Med,1997,126: 678
  • 4Hoshi S,Yoshitomi H,Komatsu N et al.Megakaryocytopoietic activity of a truncated variant of mouse thrombopietin.J Biophys Commun,1997,231: 823
  • 5O'Malley C J,Rasco J E,Basser R L et al.Administration of PEG-rHuMGDF to human stimulates the production of functional platelets that show no evidence of in vivo activiation.Blood ,1996,88: 3288
  • 6Harker L A,Roskos J E,Marzec U M et al.Effects of megakaryocyte growth and development factor on platelet production,platelet life span,and platelet function in healthy human volunteers.Blood,2000,95: 2514
  • 7KUTER DJ.Future directions with platelet growth factors[J].Seminar Hemotol,2000,37:41-49.
  • 8CHANG M,NAKAGAWA PA,WILLIAMS SA,et al.Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro[J].Blood,2003,102:887-895.
  • 9WENDLING F,MARASKOVSKY E,DEBILI N,et al.cMpl lig-and is a humoral regulator of megakaryocytopoiesis[J].Nature,1994,369:571-574.
  • 10SABATH DF,KAUSHANSKY K,BROUDY VC.Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding[J].Blood,1999,94:365-367.

共引文献142

同被引文献132

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量：104
  • 2l张之南,郝玉书,赵永强.血液病学[M].2版.北京:人民卫生出版社,2012:459-461.
  • 3Winkelmann A,K Zettl U.Use of intravenous immunoglobulin in thetreatment of immune-mediated demyelinating diseases of the nervoussystem[J].Current Pharmaceutical Design,2012,18(29):4570-4582.
  • 4AboIhassani H,Sagvand B T,Shokuhfar T,et al.A review on guidelinesfor management and treatment of common variable immunodeficiency[J].Expert Review of Clinical Immunology,2013,9(6):561-575.
  • 5Spurlock N K,Prittie J E.A review of current indications,adverse effects,and administration recommendations for intravenous immunoglobulin[J].Journal of Veterinary Emergency and Critical Care,2011,21(5):471-483.
  • 6Kuhne T,Blanchette V,Buchanan G,et al.Splenectomy in children withidiopathic thrombocytopenic purpura:a prospective study of 134 children fromthe intercontinental childhood ITP study group[J].Pediatric Blood and Cancer,2009(6):136-138.
  • 7NakazakiK, HosoiM, HangaishiA, et al. Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study[J]. Intern Med,2012,51(8):859-863. doi:10.2169/internalmedicine.51.7005.
  • 8MashhadiMA, KaykhaeiMA, SepehriZ, et al. Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia[J]. Daru,2012,20(1):7. doi:10.1186/2008-2231-20-7.
  • 9KhellafM, MichelM, SchaefferA, et al. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count[J]. Haematologica,2005,90(6):829-832.
  • 10W?rmannB. Clinical indications for thrombopoietin and thrombopoietin-receptor agonists[J]. Transfus Med Hemother,2013,40(5):319-325. doi:10.1159/000355006.

引证文献21

二级引证文献131

血栓与止血学
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部